¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"spectrum analysis, mass"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • spectrum
    1. ½ºÆåÆ®·³ 2. ¹üÀ§, ±¸¿ª
  • x-ray spectrum
    X¼±ºÐ±¤, X¼±½ºÆåÆ®·³
  • atomic mass
    ¿øÀÚÁú·®
  • atomic mass unit
    ¿øÀÚÁú·®´ÜÀ§
  • achromatic mass
    ¹«»öµ¢ÀÌ, ºñ¿°»öµ¢ÀÌ
  • body mass index
    ½Åüºñ¸¸Áö¼ö, ½ÅüÁú·®Áö¼ö
  • cavitated mass
    ¼Óºóµ¢ÀÌ
  • cell mass
    ¼¼Æ÷µ¢ÀÌ, ¼¼Æ÷±«
  • charge to mass ratio
    ÀüÇÏ´ëÁú·®ºñ
  • effective mass
    À¯È¿Áú·®
  • electronic mass
    ÀüÀÚÁú·®
  • embryonic mass
    ¹è¾Æµ¢ÀÌ
  • echogenic mass
    ¸Þ¾Æ¸®¹ß»ýµ¢ÀÌ, ¿¡Äڹ߻ýÁ¾±«
  • equivalent mass
    µî°¡Áú·®
  • fat-free body mass
    Áö¹æÁ¦¿ÜüÁß
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • system analysis
    °èÅëºÐ¼®
  • meta-analysis
    ¸ÞŸºÐ¼®
  • self-analysis
    ÀÚ±âºÐ¼®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • molecular spectrum
    ºÐÀÚ½ºÆåÆ®·³
  • prism spectrum
    ÇÁ¸®Áò½ºÆåÆ®·³
  • rotation vibration spectrum
    ȸÀüÁøµ¿½ºÆåÆ®·³
  • spectrum
    ½ºÆåÆ®·³, ºû¶ì
  • solar spectrum
    Àϱ¤½ºÆåÆ®·³
  • sound frequency spectrum
    À½ÇâÁ֯ļö½ºÆåÆ®·³
  • thermal spectrum
    ¿­¼±½ºÆåÆ®·³
  • toxin spectrum
    µ¶¼Ò½ºÆåÆ®·³
  • x-ray spectrum
    ¿¢½º¼±½ºÆåÆ®·³
  • analysis
    ºÐ¼®
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼®, ¹æ»çÈ­ºÐ¼®
  • age-period cohort analysis
    ¿¬·É±â°£ÄÚȣƮºÐ¼®
  • antigen analysis
    Ç׿øºÐ¼®
  • birth cohort analysis
    Ãâ»ýÄÚȣƮºÐ¼®
  • case analysis
    Áõ·ÊºÐ¼®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antibiotic, narrow spectrum
    ¼Ò¹üÀ§Ç×»ýÁ¦
  • antimicrobial spectrum
    Ç×±Õ(ù÷ж)½ºÆåÆ®·³.
  • antimicrobial spectrum
    Ç×±Õ(ù÷ж)½ºÆå Æ®·³.
  • antimicrobial spectrum
    Ç×±Õ¿ª(ù÷жæ´)<¹üÀ§, ½ºÆåÆ®·³>.
  • infrared spectrum
    Àû¿Ü¼± ºÐ±¤
  • infrared spectrum
    Àû¿Ü¼±ºÐ±¤
  • power spectrum in sound spectrograph
    À½Á֯ļöºÐ¼®¿¡¼­ÀÇ Á֯ļö°­µµ
  • prism spectrum
    ÇÁ¸®Áò ½ºÆåÆ®·³
  • DNA sequence analysis
    DNA ¼­¿­ºÐ¼®
  • Data analysis
    Á¤º¸ºÐ¼®
  • Decision analysis
    °áÁ¤ºÐ¼®
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼®(¡­ÝÂà°), ¹æ»çÈ­(Û¯ÞÒûù)ºÐ¼®.
  • activation analysis
    ¹æ»çÈ­ºÐ¼®, Ȱ¼ºÈ­ºÐ¼®
  • amniotic fluid analysis
    ¾ç¼öºÐ¼®
  • analysis
    ºÐ¼®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • electromagnetic spectrum
    ÀüÀڱ⠺б¤
  • emission spectrum
    ¹ßÃâ(Û¡õó)½ºÆåÆ®·³.
  • emission spectrum
    ¹ß±¤(Û¡ÎÃ)½ºÆåÆ®·³.
  • energy spectrum
    ¿¡³ÊÁöºÐ±¤
  • infrared spectrum
    Àû¿Ü¼±ºÐ±¤
  • infrared spectrum
    Àû¿Ü¼± ºÐ±¤
  • medium spectrum antibiotic
    Áß¿ªÇ×»ýÁ¦(ñéæ´ù÷ßæð¥).
  • molecular spectrum
    ºÐÀÚ½ºÆåÆ®·³.
  • narrow spectrum antibiotic
    Çù¿ªÇ×»ý¹°Áú(úõæ´ù÷ßæÚªòõ).
  • power spectrum in sound spectrograph
    À½Á֯ļöºÐ¼®¿¡¼­ÀÇ Á֯ļö°­µµ
  • prism spectrum
    ÇÁ¸®Áò ½ºÆåÆ®·³
  • rotation vibration spectrum
    ȸÀüÁøµ¿(¡­òÉÔÑ)½ºÆåÆ®·³.
  • schizophrenia spectrum disorder
    Á¤½ÅºÐ¿­º´ ¹üÁÖÀå¾Ö(º´)
  • solar spectrum
    Àϱ¤ ½ºÆåÆ®·³
  • sound frequency spectrum
    À½Ç⽺ÆåÆ®·³
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mutational spectrum
    º¯ÀÌ(ܨì¶)½ºÆåÆ®·³
  • photochemical action spectrum
    ±¤È­ÇÐÀÛ¿ë(ÎÃûùùÊíÂéÄ) ½ºÆåÆ®·³
  • Raman spectrum
    ¶ó¸¸ ½ºÆåÆ®·³
  • spectrum
    ½ºÆåÆ®·³
  • visible spectrum
    °¡½Ã(ʦãÊ) ½ºÆåÆ®·³
  • atomoc mass
    ¿øÀÚ Áú·® (ê«í­òõÕá)
  • atomoc mass unit
    ¿øÀÚ Áú·®´ÜÀ§ (ê«í­òõÕáÓ¤êÈ)
  • chemical ionization mass spectrometry
    È­ÇÐÀû(ûùùÊîÜ) ÀÌ¿ÂÈ­ Áú·®ºÐ±¤¹ý(òõÕáÝÂÎÃÛö)
  • electron ionization mass spectrometry
    ÀüÀÚ(ï³í­)ÀÌ¿ÂÈ­(ûù) Áú·® ºÐ¼®¹ý(òõÕáÝÂà°Ûö)
  • fast atom bombardment mass spectrometry
    °í¼Ó ¿øÀÚÃæ°Ý Áú·®±¤µµ°è(ÍÔáÜê«í­õú̪òõÕáÎÃÓøÍª)
  • field desorption mass spectrometry
    ÀåÅ»Âø Áú·®ºÐ±¤ÃøÁ¤¹ý (íÞ÷­ó·òõÕáÝÂÎÃö´ïÒÛö)
  • field ionization mass spectrometry
    Àå(íÞ) ÀÌ¿ÂÈ­(ûù) Áú·®ºÐ±¤ÃøÁ¤¹ý(òõÕáÝÂÎÃö´ïÒÛö)
  • gas chromatographhy-mass spectrometry
    °³½º Å©·Î¸¶Åä±×·¡ÇÇ Áú·® ºÐ±¤ÃøÁ¤¹ý(òõÕáÝÂÎÃö´ïÒÛö)
  • law of mass action
    Áú·®ÀÛ¿ë¹ýÄ¢(òõÕáíÂéÄÛööÎ)
  • lean body mass
    Å»Áö¹æÃ¼Áß(÷­ò·Û®ô÷ñì)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sequential analysis
    ¼øÂ÷ÀûºÐ¼®
  • spectral analysis
    ½ºÆåÆ®·³ºÐ¼®
  • statistical analysis
    Åë°èÀûºÐ¼®
  • urine analysis
    ¿ä°Ë»ç
  • vector analysis
    ¹éÅͺм®
  • cavitated mass
    °øµ¿¼ºÁ¾±«
  • echogenic mass
    ¿¡Äڹ߻ýÁ¾±«
  • mass
    Áú·®, Áý´Ü, ÀÀ¾î¸®, Á¾±«
  • mass effect
    Á¾±«È¿°ú
  • mass examination
    Áý´Ü°ËÁø
  • mass lesion
    Á¾±«¼ºº´º¯
  • mass miniature radiography
    Áý´ÜÃà¼Ò¹æ»ç¼±ÃÔ¿µ¼ú, Áý´Ü°£Á¢ÃÔ¿µ¼ú
  • mass miniature roentgenography
    Áý´Ü°£Á¢X¼±ÃÔ¿µ¼ú
  • mass number
    Áú·®¼ö
  • mass radiography
    Áý´Ü¹æ»ç¼±ÃÔ¿µ¼ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EADS early amnion deficit spectrum or syndrome
PSD particle size distribution; peptone, starch, and dextrose; periodic synchronous discharge; phase-sen...
SFS serial foveal seizures; skin and fascia stapler; social functioning schedule; spatial frequency spec...
MEDPAR Medical Provider Analysis and Review; Medicare Provider Analysis and Review
MRA magnetic resonance angiography; main renal artery; marrow repopulation activity; medical record anal...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MIDA Mass Isotopomer Distribution Analysis
LV mass Left ventricular mass
MS/MS mass spectrometry and -tandem mass spectrometry
MANOVA 2-multivariate analysis of variance
ANOVA ANalysis Of VAriance
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • amorphous mass deposit
    ¹«Á¤Çü Ä§Âø¹°
  • atomic mass
    ¿øÀÚ Áú·®
  • cavitated mass
    °øµ¿¼º Á¾±«
  • cell mass
    ¿ø±â ¼¼Æ÷±º
  • diffuse gingival mass
    ¹Ì¸¸¼º Ä¡Àº Á¾¾ç
  • echogenic mass
    ¿¡ÄÚ ¹ß»ý Á¾±«
  • effective mass
    À¯È¿ Áú·®
  • electronic mass
    ÀüÀÚ Áú·®
  • mass absorption coefficient
    Áú·® Èí¼ö °è¼ö
  • mass examination
    Áý´Ü °ËÁø, Áý´Ü °ËÁø °Ë»ç
  • mass increase
    ÀÀ¾î¸® Áõ°¡
  • mass lesion
    Á¾±«¼º º´º¯
  • mass miniature radiography
    Áý´Ü Ãà¼Ò ¹æ»ç¼± ÃÔ¿µ¼ú, Áý´Ü °£Á¢ ÃÔ¿µ¼ú
  • mass movement
    Áý´Ü ¿îµ¿
  • mass peristalsis
    Áý´Ü ¿¬µ¿, ´ë·® À̵¿¼º ¿¬µ¿
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
thermal spectrum The part of the invisible spectrum of wave length just longer than that of visible red light.
Synonym: thermal spectrum.
(05 Mar 2000)
toxin spectrum A figure in the form of a spectrum used by Ehrlich to represent the neutralizing power of antitoxin in the presence of toxin, toxone, etc.
(05 Mar 2000)
excitation spectrum Fluorescence produced over a range of wavelengths of the exciting light.
(05 Mar 2000)
ultraviolet spectrum The electromagnetic spectrum beyond the violet end of the visible spectrum.
(05 Mar 2000)
fluorescence spectrum Fluorescence evoked over a range of wavelengths when the excitation wavelength is at a maximum.
(05 Mar 2000)
fortification spectrum The zigzag banding of light, resembling the walls of fortified medieval towns, that marks the margin of the scintillating scotoma of migraine.
Synonym: fortification figures, telehopsias.
(05 Mar 2000)
frequency spectrum The range of frequencies in a signal, used to describe the resolving power of an imaging system in radiology.
(05 Mar 2000)
adrenal mass <radiology> Metastasis, most common (especially lung, melanoma), primary adenocarcinoma, large at diagnosis (greater than 5 cm), usually functional (increased corticosteroids most likely to be Cushing's), rapid growth, benign adrenal adenoma, with or without functional, nonfunctional occurs in 2-8% of population, diff from metastasis: MRI (metastasis bright on T2), biopsy, follow, pheochromocytoma, neuroblastoma, myelolipoma, cyst / pseudocyst see also: adrenal calcification, haemorrhage
(12 Dec 1998)
apperceptive mass The already existing knowledge base in a similar or related area with which the new perceptual material is articulated.
(05 Mar 2000)
atomic mass <chemistry, physics> The mass of an atom relative to other atoms.
The present-day basis of the scale of atomic weights is carbon, the most common isotope of this element has arbitrarily been assigned an atomic weight of 12.
The unit of the scale is 1/12 the weight of the carbon atom or roughly the mass of one proton or one neutron. The atomic weight of any element is approximately equal to the total number of protons and neutrons in is nucleus
(16 Dec 1997)
atomic mass unit <chemistry> One-twelfth the mass of a neutral atom of the most abundant isotope of carbon.
(16 Dec 1997)
bilateral adrenal mass <radiology> Acute granulomatous disease (e.g., TB), metastases (bilateral in 15%), pheochromocytoma (bilateral in 10%), adrenal hyperplasia (adenoma), spontaneous adrenal haemorrhage
(12 Dec 1998)
body mass index One of the anthropometric measures of body mass; it has the highest correlation with skinfold thickness or body density.
(12 Dec 1998)
breast mass <oncology, surgery> A breast lump may be benign or cancerous.
Examples of breast lumps include: breast abscess, fat necrosis, fibroadenoma, fibrocystic breast disease and breast cancer. A breast biopsy is the best way to determine the aetiology of a breast lump. Remember, 80 to 85% of all biopsies are benign.
(27 Sep 1997)
para-sellar mass <radiology> Mnemonic: SATCHMO, S sphenoid sinus tumour, A aneurysm / adenoma of pituitary, T teratoid lesion, C craniopharyngioma, H hypothalamic glioma / histiocytoma, M meningioma / metastasis, O optic glioma less common lesions: germinoma, epidermoid, hamartoma, chordoma, arachnoid cyst
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • job analysis
    ÀÛ¾÷ ºÐ¼®
  • market analysis
    ½ÃÀå ºÐ¼®
  • network analysis
    (¼ö)ȸ·Î(¸Á) ÇØ¼®;³×Æ®¿öÅ©ºÐ¼®;(ȸ·Î¸Á ÇØ¼® ¼ö¹ýÀ» ÀÌ¿ëÇÏ¿© ÇÁ·ÎÁ§Æ®ÀÇ °èȹ °ü¸®¸¦ÇÔ
  • neutron activation analysis
    Áß¼ºÀÚ(À¯µµ)¹æ»çÈ­ ºÐ¼®
  • nonstandard analysis
    ÃÊÁØÇؼ®
  • philosphical analysis
    öÇÐÀû ºÐ¼®
  • pollen analysis
    ²É°¡·ç ºÐ¼®;È­ºÐÇÐ
  • qualitative analysis
    Á¤¼º ºÐ¼®
  • quantitative analysis
    Á¤·® ºÐ¼®
  • systems analysis
    (´É·ü,Á¤¹Ðµµ¸¦ ³ôÀ̱â À§ÇÑ) ½Ã½ºÅÛ ºÐ¼®
  • ultimate analysis
    ¿ø¼Ò ºÐ¼®
  • ultimate analysis
    ¿ø¼Ò ºÐ¼®
  • mass
    µ¢¾î¸®,´ëÁß,Áý´Ü,´Ù·®,¹Ì»ç
  • Dialogue Mass
    (õÁÖ±³)´ëÈ­ ¹Ì»ç
  • Low Mass
    Æò¹Ì»ç
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á